# EDGAR Filing Document

**Accession Number:** 0001162194
**File Stem:** 0001162194-23-000008
**Filing Date:** 2023-2
**Character Count:** 8058
**Document Hash:** 4fa45a05fe1476b29fafff7c09de9fa9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001162194-23-000008.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001162194-23-000008

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230221

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** JOG VIKRAM
- **CENTRAL INDEX KEY:** 0001222641

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34180
- **FILM NUMBER:** 23661995

**MAIL ADDRESS:**
- **STREET 1:** C/O FLUIDIGM CORPORATION
- **STREET 2:** 7000 SHORELINE COURT, SUITE 100
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STANDARD BIOTOOLS INC.
- **CENTRAL INDEX KEY:** 0001162194
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **IRS NUMBER:** 770513190
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2 TOWER PLACE
- **STREET 2:** SUITE 2000
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 6502666000

**MAIL ADDRESS:**
- **STREET 1:** 2 TOWER PLACE
- **STREET 2:** SUITE 2000
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FLUIDIGM CORP
- **DATE OF NAME CHANGE:** 20011113

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>JOG VIKRAM<br><sub>(Last) (First) (Middle)</sub><br>C/O STANDARD BIOTOOLS INC.<br>2 TOWER PLACE, STE 2000<br><sub>(Street)</sub><br>SOUTH SAN FRANCISCO, CA 94080<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-21 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>STANDARD BIOTOOLS INC. [ LAB ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-21 |  | M |  | 50000 | A | $0 | 221904 | D |  |
| Common Stock | 2023-02-21 |  | M |  | 16666 | A | $0 | 238570 | D |  |
| Common Stock | 2023-02-21 |  | M |  | 2238 | A | $0 | 240808 | D |  |
| Common Stock | 2023-02-21 |  | M |  | 2391 | A | $0 | 243199 | D |  |
| Common Stock | 2023-02-21 |  | M |  | 3130 | A | $0 | 246329 | D |  |
| Common Stock | 2023-02-21 |  | F |  | 28707 | D | $2.03 | 217622 | D |  |
| Common Stock |  |  |  |  |  |  |  | 52061 | I | See Footnote<sup>(1)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-21 |  | M |  |  | 50000 | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 50000.0 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-21 |  | M |  |  | 16666 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 16666.0 | $0 | 183334 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-21 |  | M |  |  | 2238 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2238.0 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-21 |  | M |  |  | 2391 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 2391.0 | $0 | 9563 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-21 |  | A |  |  | 3130 | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 3130.0 | $0 | 28176 | D |  |

---

### Footnotes:

(1) Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.

(2) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

(3) The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."

(4) On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.

(5) On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

(6) On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

(7) On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

**Signature:** /s/ Vikram Jog  
**Date:** 2023-02-23

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**